Allan Powe

876 total citations
9 papers, 725 citations indexed

About

Allan Powe is a scholar working on Physiology, Molecular Biology and Cell Biology. According to data from OpenAlex, Allan Powe has authored 9 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Molecular Biology and 4 papers in Cell Biology. Recurrent topics in Allan Powe's work include Lysosomal Storage Disorders Research (6 papers), Cellular transport and secretion (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Allan Powe is often cited by papers focused on Lysosomal Storage Disorders Research (6 papers), Cellular transport and secretion (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Allan Powe collaborates with scholars based in United States, Germany and Canada. Allan Powe's co-authors include Brandon A. Wustman, Richie Khanna, Stephen Chung, Richard Steet, Hung Do, Stuart Kornfeld, Kenneth J. Valenzano, Elfrida R. Benjamin, Dagmar Ringe and Gregory A. Petsko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Journal of Physiology.

In The Last Decade

Allan Powe

8 papers receiving 705 citations

Peers

Allan Powe

PHYSI

MB

OC

CB

EPIDE

Elfrida R. Benjamin United States

Yi Lun United States

Sunqu Zhang Canada

Sulochanadevi Baskaran United States

Lihsueh Lee United States

Ladislav Kuchař Czechia

Srinivasa S. Raghavan United States

Werner Fürst Germany

María H. Granado Spain

Chor Hui Vivien Koh Singapore

Elfrida R. Benjamin United States

Allan Powe

800 ×1.5

PHYSI

355 ×1.1

MB

388 ×1.4

OC

325 ×1.2

CB

334 ×2.0

EPIDE

Citations per year, relative to Allan Powe Allan Powe (= 1×) peers Elfrida R. Benjamin

Countries citing papers authored by Allan Powe

Since Specialization

Citations

This map shows the geographic impact of Allan Powe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan Powe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan Powe more than expected).

Fields of papers citing papers by Allan Powe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan Powe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan Powe. The network helps show where Allan Powe may publish in the future.

Co-authorship network of co-authors of Allan Powe

This figure shows the co-authorship network connecting the top 25 collaborators of Allan Powe. A scholar is included among the top collaborators of Allan Powe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan Powe. Allan Powe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Khanna, Richie, Allan Powe, Yi Lun, et al.. (2014). The Pharmacological Chaperone AT2220 Increases the Specific Activity and Lysosomal Delivery of Mutant Acid Alpha-Glucosidase, and Promotes Glycogen Reduction in a Transgenic Mouse Model of Pompe Disease. PLoS ONE. 9(7). e102092–e102092. 31 indexed citations

2.

Valenzano, Kenneth J., Richie Khanna, Allan Powe, et al.. (2011). Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage Disorders. Assay and Drug Development Technologies. 9(3). 213–235. 127 indexed citations

3.

Khanna, Richie, Elfrida R. Benjamin, Lee Pellegrino, et al.. (2010). The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β‐glucosidase. FEBS Journal. 277(7). 1618–1638. 127 indexed citations

4.

Khanna, Rajiv, Yi Lun, Allan Powe, et al.. (2009). G.P.8.05 The pharmacological chaperone AT2220 increases mutant acid alpha-glucosidase levels and reduces tissue glycogen in a mouse model of Pompe disease. Neuromuscular Disorders. 19(8-9). 592–592. 1 indexed citations

5.

Lieberman, Raquel L., Brandon A. Wustman, Pedro E. Huertas, et al.. (2006). Structure of acid β-glucosidase with pharmacological chaperone provides insight into Gaucher disease. Nature Chemical Biology. 3(2). 101–107. 191 indexed citations

6.

Steet, Richard, Stephen Chung, Brandon A. Wustman, et al.. (2006). The iminosugar isofagomine increases the activity of N370S mutant acid β-glucosidase in Gaucher fibroblasts by several mechanisms. Proceedings of the National Academy of Sciences. 103(37). 13813–13818. 180 indexed citations

7.

Powe, Allan, Zhen Zhou, Tzyh‐Chang Hwang, & Georg Nagel. (2003). Quantitative Analysis of ATP-Dependent Gating of CFTR. Humana Press eBooks. 70. 67–98. 2 indexed citations

8.

Powe, Allan, Layla Al‐Nakkash, Min Li, & Tzyh‐Chang Hwang. (2002). Mutation of Walker‐A lysine 464 in cystic fibrosis transmembrane conductance regulator reveals functional interaction between its nucleotide‐binding domains. The Journal of Physiology. 539(2). 333–346. 57 indexed citations

9.

Powe, Allan, Douglas Strathdee, Tyler Cutforth, et al.. (1999). In vivo functional analysis of Drosophila Gap1: involvement of Ca2+ and IP4 regulation. Mechanisms of Development. 81(1-2). 89–101. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact